According to OKYO Pharma's latest financial reports the company's current EPS (TTM) is -HK$3.85. In 2022 the company made an earnings per share (EPS) of -HK$3.85 an increase over its 2021 EPS that were of -HK$5.06.
Year | EPS | Change |
---|---|---|
2022 | -HK$3.85 | -23.88% |
2021 | -HK$5.06 | 285.65% |
2020 | -HK$1.31 | -71.55% |
2019 | -HK$4.61 | -87.01% |
2018 | -HK$35.50 | 3917.84% |
2017 | -HK$0.88 | -18.97% |
2016 | -HK$1.09 | -90.16% |
2015 | -HK$11.09 | -52.63% |
2014 | -HK$23.40 | 181.93% |
2013 | -HK$8.30 | 3547.06% |
2012 | -HK$0.23 | -90.67% |
2011 | -HK$2.44 | -112.7% |
2010 | HK$19.20 | -14.64% |
2009 | HK$22.49 | -183.01% |
2008 | -HK$27.10 |